Recent Finacing
Recent Raise
Ability Biologics develops logic-gated, fully human IgG-based multispecific antibodies responsive to cellular microenvironment cues using AbiLeap, an AI and antigen–antibody database discovery engine.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ability biologics.
